Fundraising FoxEscient Pharmaceuticals
San Diego, US · Founded 2017 · 9 known investors
Find your way into Escient Pharmaceuticals
Sign up to see every warm intro you have to Escient Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Escient Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Company developing molecules targeting a novel class of receptors for neuro-immuno-inflammatory diseases; acquired by Incyte in May 2024.
Founders & leadership
Escient Pharmaceuticals was founded in 2017 by Alain Baron.
Board
Investors · 9
How we know: 5AM Ventures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: Avego BioScience Capital's portfolio page · Not right? Tell us
How we know: funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: The Column Group's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$108.8M disclosed across 3 rounds · 2018–2022
▶$60MraisedNov 2022 · 22 investors · BiotechnologyRule 506(b)
- Peter HirthDirector
- Charles ZukerDirector
- Kathleen Sereda GlaubDirector
- Jason HaflerDirector
- Kevin RaidyDirector
- Aaron MishelExecutive Officer
- Joshua GrassExecutive Officer, Director
- JeenJoo KangDirector
- Andrew SchwabDirector
- Marcus BoehmExecutive Officer
- Offering amount
- $120M
- Amount sold
- $60M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.8MraisedSep 2020 · 18 investors · BiotechnologyRule 506(b)
- Marcus BoehmExecutive Officer
- Charles ZukerDirector
- Kevin RaidyDirector
- Kathleen GlaubDirector
- Alain BaronExecutive Officer, Director
- Andrew SchwabDirector
- JeenJoo KangDirector
- Jason HaflerDirector
- Peter HirthDirector
- Offering amount
- $77.5M
- Amount sold
- $38.8M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$10MraisedApr 2018 · 10 investors · BiotechnologyRule 506(b)
- JeenJoo KangDirector
- Robert TjianDirector
- Alain BaronExecutive Officer, Director
- Marcus BoehmExecutive Officer
- Andrew SchwabDirector
- Offering amount
- $40M
- Amount sold
- $10M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Escient Pharmaceuticals went on to found or lead other companies.
In the news
Frequently asked questions
- What does Escient Pharmaceuticals do?
- Company developing molecules targeting a novel class of receptors for neuro-immuno-inflammatory diseases; acquired by Incyte in May 2024.
- Who founded Escient Pharmaceuticals?
- Escient Pharmaceuticals was founded by Alain Baron in 2017.
- Who are Escient Pharmaceuticals's investors?
- Escient Pharmaceuticals's investors include 5AM Ventures, Avego BioScience Capital, New Enterprise Associates (NEA), OUP (Osage University Partners), Sanofi Ventures, The Column Group, Abingworth, ALTITUDE LIFE SCIENCE VENTURES and 1 more.
- How much funding has Escient Pharmaceuticals raised?
- Escient Pharmaceuticals has disclosed $108.8M raised across 3 rounds.
- Where is Escient Pharmaceuticals headquartered?
- Escient Pharmaceuticals is headquartered in San Diego, US.